{
    "2019-03-19": [
        [
            {
                "time": "2019-03-19",
                "original_text": "After Hours Most Active for Mar 19, 2019: TFCFA, TFCF, LLY, BRX, TWTR, BAC, PFE, EBAY, S, MSFT, CMCSA, INTC",
                "features": {
                    "keywords": [
                        "Most Active",
                        "LLY",
                        "BRX",
                        "TWTR",
                        "BAC",
                        "PFE",
                        "EBAY",
                        "MSFT",
                        "CMCSA",
                        "INTC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "Why Analysts Still Favor Eli Lilly and Company Stock",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Favor",
                        "Eli Lilly",
                        "Company Stock"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-19",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "report",
                        "Eli Lilly",
                        "Co."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}